Dr. Peng Yin has been with Abbott for 14 years since 2004. Currently, Dr. Yin is the Head of Abbott Diagnostics China R&D Center in Shanghai since 2014. Prior to his current role, he was the Global Scientific and Medical Affairs Director, Abbott Diagnostics in Chicago. Prior to joining Abbott, Dr. Yin worked as a Senior Scientist at Zycos in Lixington, MA for four years; and practiced as an Abdominal Surgeon for 5 years in Tianjin, China.
Dr. Yin currently is a Fellow of the National Academy of Clinical Biochemistry (FACB); previous chair of Industry Division, AACC; Executive Committee Member of the Emerging Technology Division, IFCC, previous Congresses and the Conference Executive Committee Member, IFCC; as well as the Member of Biological Diagnostic Technology, Branch of China Medicinal Biotechnology Association; Committee Member of China Diagnostic New Technology and New Material Biomarker Group; the honorary professor of Tianjin Medical University Cardiovascular Institute and TEDA International Cardiovascular Hospital in China. He is also on the editorial board of both Journal of Human Virology & Retro Virology and Journal of Virology & Current Research. He has published many high quality scientific research papers in the world’s leading science journals such as Cell, Nature, and Journal of Virology.
Dr. Peng Yin earned his Medical Doctor Degree (M.D.) from Tianjin Medical School in China in 1987 and a Ph.D. in Molecular Virology from University of Manitoba in Canada in 1998. He also completed his postdoctoral training at Harvard University Medical School in 2000.